EL4Z:XETRA:XETRA-Deka MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 45.067

Change

+0.05 (+0.11)%

Market Cap

USD 0.33B

Volume

2.26K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.11 (-0.21%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.03 (-0.18%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.12 (-0.44%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.14 (-0.49%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.09 (+0.36%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.10 (-0.07%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.04 (+0.08%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.40 (+0.28%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.09 (-0.17%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.84 (+0.55%)

USD 80.38B

ETFs Containing EL4Z:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.12% 82% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.12% 82% B 80% B-
Trailing 12 Months  
Capital Gain 27.55% 86% B+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.55% 86% B+ 85% B
Trailing 5 Years  
Capital Gain 81.21% 92% A 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 81.21% 92% A 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 12.83% 86% B+ 82% B
Dividend Return 13.29% 87% B+ 82% B
Total Return N/A 53% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 14.77% 41% F 52% F
Risk Adjusted Return 89.97% 97% N/A 96% N/A
Market Capitalization 0.33B 59% D- 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.